|
dementia |
15 |
|
epidemiology |
10 |
|
memory |
10 |
|
depression |
9 |
|
dose-dependent effect |
8 |
|
hallucination |
8 |
|
latent class analysis |
8 |
|
persistent psychotic experience |
8 |
|
schizophrenia |
8 |
|
adults |
6 |
|
affective psychoses |
6 |
|
aged |
6 |
|
anxiety |
6 |
|
anxiety disorders |
6 |
|
asian continental ancestry group |
6 |
|
communityolder |
6 |
|
health surveys |
6 |
|
interview, psychological |
6 |
|
lifetime prevalence |
6 |
|
mental disorders / epidemiology |
6 |
|
meta-analysis |
6 |
|
population surveys |
6 |
|
prevalence |
6 |
|
systematic review |
6 |
|
accident prevention |
5 |
|
accidental falls |
5 |
|
cognitive disorders |
5 |
|
exercise |
5 |
|
mental health |
5 |
|
public health |
5 |
|
transcranial direct current stimulation |
5 |
|
brain stimulation |
4 |
|
cognitive impairment |
4 |
|
health service utilization |
4 |
|
mental disorders |
4 |
|
methamphetamine |
4 |
|
mild cognitive impairment |
4 |
|
pulmonary hypertension |
4 |
|
screening |
4 |
|
alzheimer's disease |
3 |
|
biomarkers |
3 |
|
classification |
3 |
|
cognitive dysfunction |
3 |
|
diurnal cortisol rhythm |
3 |
|
early dementia |
3 |
|
episodic |
3 |
|
episodic memory |
3 |
|
housing |
3 |
|
instrumental activities of daily living |
3 |
|
living environment |
3 |
|
longitudinal change |
3 |
|
mindfulness |
3 |
|
neighbourhood |
3 |
|
psychological distress |
3 |
|
psychophysiology |
3 |
|
subjective mood |
3 |
|
transcranial direct current stimulation (tdcs) |
3 |
|
transcranial magnetic stimulation |
3 |
|
anodal transcranial |
2 |
|
antipsychotic agents - therapeutic use |
2 |
|
brain |
2 |
|
caregivers |
2 |
|
cognitive function |
2 |
|
cortical thickness |
2 |
|
covid-19 |
2 |
|
delirium - psychology |
2 |
|
dementia - psychology |
2 |
|
home-based exercise |
2 |
|
humans |
2 |
|
magnetic resonance imaging |
2 |
|
neurocognitive disorder |
2 |
|
neuropsychological performance |
2 |
|
old age |
2 |
|
parkinson disease - psychology |
2 |
|
prefrontal cortex |
2 |
|
psychotic disorders - drug therapy |
2 |
|
randomised controlled trial |
2 |
|
randomized clinical trial |
2 |
|
schizophrenia - drug therapy |
2 |
|
suicide |
2 |
|
tai chi |
2 |
|
working memory |
2 |
|
activities of daily living - classification - psychology |
1 |
|
adaptation, psychological |
1 |
|
adolescent |
1 |
|
adult |
1 |
|
age |
1 |
|
age distribution |
1 |
|
age factors |
1 |
|
aged - statistics & numerical data |
1 |
|
aged, 80 and over |
1 |
|
ageing |
1 |
|
aging |
1 |
|
aging - psychology |
1 |
|
alzheimer disease |
1 |
|
alzheimer disease - diagnosis - drug therapy - psychology |
1 |
|
alzheimer disease - ethnology - psychology - therapy |
1 |
|
alzheimer’s disease |
1 |
|
analysis of variance |
1 |
|
apoe genotype |
1 |
|
area under curve |
1 |
|
aromatherapy |
1 |
|
asian continental ancestry group - psychology |
1 |
|
asian continental ancestry group - psychology - statistics & numerical data |
1 |
|
attitude to health |
1 |
|
behavior |
1 |
|
behavioral symptoms |
1 |
|
body mass index |
1 |
|
cardiovascular diseases - etiology |
1 |
|
caregivers - psychology |
1 |
|
china |
1 |
|
chinese |
1 |
|
cholinesterase inhibitors |
1 |
|
clinical dementia rating |
1 |
|
cluster-randomized controlled trial |
1 |
|
cognition - physiology |
1 |
|
cognition disorders |
1 |
|
cognition disorders - complications |
1 |
|
cognition disorders - complications - diagnosis - ethnology |
1 |
|
cognition disorders - diagnosis - epidemiology |
1 |
|
cognition disorders - diagnosis - epidemiology - psychology |
1 |
|
cognition disorders - epidemiology - etiology |
1 |
|
cognition disorders - etiology |
1 |
|
cognitive decline |
1 |
|
complementary therapies |
1 |
|
control groups |
1 |
|
cost of illness |
1 |
|
cross-over studies |
1 |
|
cross-sectional studies |
1 |
|
data collection |
1 |
|
data collection - statistics & numerical data |
1 |
|
dementia - complications |
1 |
|
dementia - diagnosis - epidemiology |
1 |
|
dementia - diagnosis - epidemiology - psychology |
1 |
|
dementia - diagnosis - psychology |
1 |
|
dementia - epidemiology |
1 |
|
dementia caregiving |
1 |
|
dementia, vascular - diagnosis - drug therapy - psychology |
1 |
|
depression - complications - diagnosis - ethnology |
1 |
|
depression - epidemiology - etiology |
1 |
|
diagnosis, differential |
1 |
|
diagnostic and statistical manual of mental disorders |
1 |
|
disability assessment for dementia |
1 |
|
disability evaluation |
1 |
|
disease progression |
1 |
|
donepezil |
1 |
|
double-blind method |
1 |
|
education |
1 |
|
educational status |
1 |
|
efficacy |
1 |
|
epidemiologic methods |
1 |
|
ethnicity |
1 |
|
exercise - physiology |
1 |
|
family - psychology |
1 |
|
female |
1 |
|
follow-up studies |
1 |
|
functional disabilities |
1 |
|
geriatric assessment |
1 |
|
geriatric assessment - methods |
1 |
|
geriatric assessment - methods - statistics & numerical data |
1 |
|
geriatric assessment - methods - statistics and numerical data |
1 |
|
geriatric assessment - statistics & numerical data |
1 |
|
geriatric psychiatry |
1 |
|
glycemic changes |
1 |
|
haloperidol - adverse effects - therapeutic use |
1 |
|
health care policy |
1 |
|
homes for the aged |
1 |
|
hong kong |
1 |
|
hong kong - epidemiology |
1 |
|
incidence |
1 |
|
lavandula |
1 |
|
logistic models |
1 |
|
longitudinal studies |
1 |
|
male |
1 |
|
mass screening - methods |
1 |
|
memory disorders - diagnosis - epidemiology - psychology |
1 |
|
mental disorders - complications - epidemiology |
1 |
|
mental disorders - epidemiology - psychology |
1 |
|
mental health services - standards |
1 |
|
mental recall |
1 |
|
mental status schedule |
1 |
|
middle aged |
1 |
|
mild cognitive impairment - diagnosis |
1 |
|
mind-body therapies |
1 |
|
nerve degeneration - complications - diagnosis - ethnology |
1 |
|
neuropsychological tests |
1 |
|
neuropsychological tests - standards - statistics & numerical data |
1 |
|
neuropsychological tests - statistics & numerical data |
1 |
|
nursing homes |
1 |
|
obesity |
1 |
|
obsessive-compulsive disorder - psychology |
1 |
|
older adults |
1 |
|
outcome |
1 |
|
parkinson disease, secondary - etiology - psychology |
1 |
|
parkinsonian disorders |
1 |
|
parkinsonian disorders - diagnosis - psychology |
1 |
|
pathways to care |
1 |
|
pharmacogenetics |
1 |
|
physical fitness |
1 |
|
poor vision |
1 |
|
positive aspects of caregiving |
1 |
|
predictive value of tests |
1 |
|
prodrome |
1 |
|
prognosis |
1 |
|
progression |
1 |
|
prospective studies |
1 |
|
psychiatric status rating scales |
1 |
|
psychiatric status rating scales - statistics & numerical data |
1 |
|
psychomotor agitation - ethnology - psychology - therapy |
1 |
|
public education |
1 |
|
public opinion |
1 |
|
qualitative research |
1 |
|
regression analysis |
1 |
|
reproducibility of results |
1 |
|
residence characteristics |
1 |
|
risk factor |
1 |
|
risk factors |
1 |
|
risperidone - adverse effects - therapeutic use |
1 |
|
roc curve |
1 |
|
sampling studies |
1 |
|
sensitivity and specificity |
1 |
|
severity of illness index |
1 |
|
sex |
1 |
|
sex factors |
1 |
|
social behavior disorders - diagnosis |
1 |
|
social behavior disorders - diagnosis - drug therapy - psychology |
1 |
|
social stigma |
1 |
|
statistics, nonparametric |
1 |
|
stigma |
1 |
|
task performance and analysis |
1 |
|
time factors |
1 |
|
tolerability |
1 |
|
treatment outcome |
1 |
|
type 2 diabetes |
1 |
|
visual impairment |
1 |
